Results 281 to 290 of about 53,596 (333)

EGFR mutations in patients with lung adenocarcinoma and malignant pleural effusion: a propensity score-matched analysis of a single-center database. [PDF]

Transl Lung Cancer Res
Yang Q, Wang Z, Fu Q, Hu X, Chen L, Chen W, Lv L, Liu Z, Men W, Li D, Li W.   +10 more
europepmc   +1 more source

β-receptor blocker enhances anti-tumor immunity via inhibiting lactate-induced norepinephrine metabolism of macrophages during malignant pleural effusion. [PDF]

Front Immunol
Zhang R, Wang W, Li A, Wang H, Liu X, Fan F, Wang Y, Zhang H, Chang J, Zhang Y, Wang H, Miao L, Huang B, Yang L, Zhang Y.   +14 more
europepmc   +1 more source

Establishment of lung cancer cell lines and tumorigenesis in mice from malignant pleural effusion in patients with lung cancer. [PDF]

Transl Lung Cancer Res
Kanaji N, Yokohira M, Inoue T, Watanabe N, Mizoguchi H, Komori Y, Kawada K, Kadowaki N.   +7 more
europepmc   +1 more source

Malignant pleural effusion facilitates the establishment and maintenance of tumor organoid biobank with multiple patient-derived lung tumor cell sources. [PDF]

Exp Hematol Oncol
Wang L, Yu Y, Fang Y, Li Y, Yu W, Wang Z, Lv J, Wang R, Liang S.   +8 more
europepmc   +1 more source

Malignant Pleural Effusions [PDF]

Seminars in Respiratory and Critical Care Medicine, 1985
Various diseases of the gastrointestinal tract at times are accompanied by an exudative pleural effusion. The exudative pleural effusions resulting from esophageal perforation, pancreatic disease, subphrenic abscess, intrahepatic abscess, splenic abscess, abdominal operations, and diaphragmatic hernia are discussed in this article.
openaire   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Malignant pleural effusions

Cancer Treatment Reviews, 1978
Recurrent malignant pleural effusion is a relatively common problem that often occurs many months before the terminal stages of a patient's malignant disease. Despite careful evaluation, it is often impossible to identify the exact physiologic cause of an effusion and difficult to identify a pragmatic course of therapy.
Michael A. Friedman, Evan Slater
openaire   +3 more sources

Pleurodesis for malignant pleural effusions

Cochrane Database of Systematic Reviews, 2000
Approximately half of all patients with metastatic cancer develop a malignant pleural effusion which is likely to lead to a significant reduction in quality of life secondary to symptoms such as dyspnoea and cough. The aim of pleurodesis in these patients is to prevent re-accumulation of the effusion and thereby of symptoms, and avoid the need for ...
Roshan Agarwal, Paul Shaw
openaire   +4 more sources

Malignant Pleural Effusions

Clinics in Chest Medicine, 2013
Malignant pleural effusions are a cause of significant symptoms and distress in patients with end-stage malignancies and portend a poor prognosis. Management is aimed at symptom relief, with minimally invasive interventions and minimal requirement for hospital length of stay.
Ali I. Musani, Justin Thomas
openaire   +3 more sources